Introducing Gefitinib, the generic for Iressa, Anti-Cancer Tablet – a selective epidermal growth factor receptor (EGFR) inhibitor designed to treat non-small cell lung cancer. It blocks aberrant signaling pathways, reducing tumor cell proliferation and promoting apoptosis. Experience significant tumor regression, improved progression-free survival, and enhanced quality of life with this advanced targeted therapy.